Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Leukemia 12Breast Neoplasms 9Neoplastic Cells, Circulating 7Prostatic Neoplasms 5Leukemia, Myeloid, Acute 5Multiple Myeloma 4Lung Neoplasms 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Wilms Tumor 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms, Plasma Cell 3Kidney Neoplasms 3Congenital Abnormalities 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Intraductal, Noninfiltrating 3Unspecified Adult Solid Tumor, Protocol Specific 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Ovarian Neoplasms 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms, Male 2Adenocarcinoma Of Esophagus 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1

Interventions

Irinotecan 30Paclitaxel 24Gemcitabine 21Cisplatin 21Docetaxel 19Fluorouracil 15alvocidib 12Oxaliplatin 11Leucovorin 11Carboplatin 11Capecitabine 11Bortezomib 9Taxes 8Topotecan 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7Vorinostat 6Immunohistochemistry 6tanespimycin 5Temozolomide 5Sorafenib 5Pemetrexed 5Early Intervention, Educational 5Chromatography, High Pressure Liquid 5Bevacizumab 57-hydroxystaurosporine 57-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine 5ixabepilone 4bryostatin 1 4Sirolimus 4Pharmacogenomic Testing 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Unspecified Adult Solid Tumor, Protocol Specific × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00372736 2023-08-04

AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

Canadian Cancer Trials Group

Phase 1 Completed
27 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00389922 2012-04-19

Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors

University of California, Davis

Phase 1 Completed
22 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡